HCMV pUL135 Remodels the Actin Cytoskeleton to Impair Immune Recognition of Infected Cells  by Stanton, Richard J. et al.
Cell Host & Microbe
ArticleHCMV pUL135 Remodels the Actin Cytoskeleton
to Impair Immune Recognition of Infected Cells
Richard J. Stanton,1,9,* Virginie Prod’homme,1,9 Marco A. Purbhoo,2 Melanie Moore,1 Rebecca J. Aicheler,1
Marcus Heinzmann,3 Susanne M. Bailer,3,4 Ju¨rgen Haas,3 Robin Antrobus,5 Michael P. Weekes,5 Paul J. Lehner,5
Borivoj Vojtesek,6 Kelly L. Miners,1 Stephen Man,7 Gavin S. Wilkie,8 Andrew J. Davison,8 Eddie C.Y. Wang,1
Peter Tomasec,1 and Gavin W.G. Wilkinson1,*
1Institute of Infection & Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK
2Section of Hepatology, Department of Medicine, Imperial College London, London, W2 1PG, UK
3Ludwig-Maximilians-Universita¨t Mu¨nchen, Max von Pettenkofer-Institut, Pettenkoferstrasse 9a, 80336 Mu¨nchen, Germany
4Biological Interfacial Engineering, University of Stuttgart, Nobelstrasse 12, 70569 Stuttgart, Germany
5University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, UK
6Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic
7Institute of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK
8Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow G11 5JR, UK
9Co-first author
*Correspondence: stantonrj@cf.ac.uk (R.J.S.), wilkinsongw1@cf.ac.uk (G.W.G.W.)
http://dx.doi.org/10.1016/j.chom.2014.07.005
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
Immune evasion genes help human cytomegalovirus
(HCMV) establish lifelong persistence. Without im-
mune pressure, laboratory-adapted HCMV strains
have undergone genetic alterations. Among these,
the deletion of the UL/b’ domain is associated with
loss of virulence. In a screen of UL/b’, we identified
pUL135 as a protein responsible for the character-
istic cytopathic effect of clinical HCMV strains that
also protected from natural killer (NK) and T cell
attack. pUL135 interacted directly with abl interactor
1 (ABI1) and ABI2 to recruit the WAVE2 regulatory
complex to the plasma membrane, remodel the actin
cytoskeleton and dramatically reduce the efficiency
of immune synapse (IS) formation. An intimate asso-
ciation between F-actin filaments in target cells and
the IS was dispelled by pUL135 expression. Thus,
F-actin in target cells plays a critical role in synapto-
genesis, and this can be exploited by pathogens to
protect against cytotoxic immune effector cells. An
independent interaction between pUL135 and talin
disrupted cell contacts with the extracellular matrix.
INTRODUCTION
Human cytomegalovirus (HCMV) is a clinically important path-
ogen, given that it is the leading infectious cause of congenital
disorders and frequently associated with severe morbidity and
mortality in immunocompromised individuals. HCMV exploits
an impressive arsenal of immune evasion genes in order to
establish lifelong persistence in its host; the virus is a paradigm
of viral immune evasion. The suppression of MHC-I expression
by at least four HCMV genes (US2, US3, US6, and US11) isCell Hoswell-characterized and promotes evasion of cytotoxic T lympho-
cytes. However, natural killer (NK) cells play a critical role in
controlling CMV infection. Given that MHC-I also constitute the
chief NK cell inhibitory ligands, their downregulation has the
potential to render infected cells vulnerable to NK cell attack.
Our understanding of human NK cell biology and HCMV patho-
genesis has been greatly enhanced by studies into how HCMV
systematically evades NK cell activation.
To counter NK cells, HCMV encodes a MHC-I homolog
(gpUL18), and a peptide derived from the signal peptide of
UL40 (SPUL40) stabilizes both gpUL18 and the nonclassical
MHC-I molecule HLA-E (Prod’homme et al., 2012; Tomasec
et al., 2000). gpUL18 binds the inhibitory receptor LIR-1 1,000-
fold more efficiently than endogenous MHC-I (Chapman et al.,
1999; Prod’homme et al., 2007), whereas the rescue of HLA-E
by SPUL40 provides an inhibitory signal via CD94/NKG2A+. NK
cells also respond to activating signals. The activating receptor
NKG2D binds eight stress proteins (MICA, MICB, and ULBP1–
ILBP6), and HCMV encodes at least five genes (US18, US20,
UL16, UL142, and miR-UL112) that suppress their cell-surface
expression (Fielding et al., 2014; Wilkinson et al., 2008). CD112
and CD155 become exposed when infection disrupts intercel-
lular contacts and serve as ligands for the activating receptors
CD226 and CD96, and gpUL141 suppresses cell-surface
expression of both (Prod’homme et al., 2010; Tomasec et al.,
2005). Moreover, the tegument protein pp65 binds directly to
NKp30, inhibiting NK cell cytotoxicity (Arnon et al., 2005). NK
cells can also kill target cells through direct ligation of death
receptors, and gpUL141 contributes toward NK cell evasion by
downregulating TRAIL receptor 2 (Smith et al., 2013).
HCMV laboratory-adapted strains have accumulated genetic
defects during in vitro passage (Dargan et al., 2010; Stanton
et al., 2010), the most extreme being a 15 kb deletion of
the UL/b’ region (genes UL133–UL150) in strain AD169. Loss of
UL/b’ correlates with greatly enhanced sensitivity to NK cell
attack (Cerboni et al., 2000; Tomasec et al., 2005; Wang et al.,
2002), which is ascribed in part to loss of UL141 and UL142. Int & Microbe 16, 201–214, August 13, 2014 ª2014 The Authors 201
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Table 1. NK Clone Cytotoxicity
D3 NK Clones Activationa Inhibitionb No Changec No Killingd
RAd-UL141 4/28
(14.3%)
7/28
(25%)
10/28 (35.7%) 7/28 (25%)
RAd-UL135 0/28 (0%) 14/28
(50%)
5/28 (17.9%) 9/28 (32.1%)
D2 NK Clones Activation Inhibition No Change No Killing
RAd-UL141 3/29
(10.3%)
12/29
(41.4%)
9/29 (31%) 5/29 (17.2%)
RAd-UL135 0/29 (0%) 18/29
(62.1%)
6/29 (20.7%) 5/29 (17.2%)
All NK Clones Activation Inhibition No Change No Killing
RAd-UL141 7/57
(12.3%)
19/57
(33.3%)
19/57 (33.3%) 12/57 (21%)
RAd-UL135 0/57 (0%) 32/57
(56.1%)
11/57 (19.3%) 14/57 (24.6%)
Data show the number and percentage of NK clones isolated from
PBMC.
aActivated NK clones kill RAd-UL141/RAd-UL135-infected autologous
SF with specific lysis > 10% in comparison to RAd-Ctrl.
bInhibited NK clones kill RAd-Ctrl-infected SF with specific lysis > 10%
in comparison to RAd-UL141 or RAd-UL135.
cNK clones with no change kill RAd-UL141 or RAd-UL135-infected SF
with specific lysis < 10% in comparison to RAd-Ctrl.
dNK clones with no killing kill RAd-Ctrl-infected SF with specific
lysis < 10%.
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evasion function within UL/b’. pUL135 was unique in providing
efficient protection against not only an exceptionally broad range
of NK as well as T cells. Classically, NK cell modulatory functions
either promote cell surface expression of inhibitory ligands or
suppress activating ligands; however, pUL135’s mechanism of
action is different. Dynamic remodeling of the actin cytoskeleton
within effector cells plays a major role in organizing the immune
synapse (IS) and promoting degranulation in cytotoxic T lympho-
cytes (CTLs) and NK cells. Biochemical, genetic, and functional
studies performed on pUL135 identified an interaction with abl
interactor 1(ABI1) and ABI2, recruitment of the WAVE2 complex,
and subsequent actin depolymerization in target cells as critical
in evading NK cell recognition. Direct imaging identified anFigure 1. UL135 Decreases NK Cell Cytotoxicity, Degranulation, and I
IFN-g Production
(A–E) Cytotoxicity assays were set up with the NKL cell line against HFFF-hC
IFN-a-activated T-cell-depleted PBMC against autologous skin fibroblasts (SFs;
against HFFF-hCAR (D) or autologous SF (E).
(F) Intracellular IFN-g stainings were set up with IFN-a-activated PBMC against
(G) Adhesion assays were performed with HFFF-hCAR infected with RAd-UL135
(H) T cell degranulation assays were set up with the 7E7 T cell clone against MRC
peptide are shown as controls.
(I–J) T cell intracellular IFN-g staining assays were set up with the D7IE1 (I) and D7p
and pulsed with peptide.
(K–L) NK cell degranulation assays were set up with IFN-a-activated PBMC agai
strains AD169, Merlin, MerlinDUL135, MerlinDUL141, MerlinDUL135/DUL141, or
(M) T cell degranulation assays were set up with a pp65-specific T cell line agains
(N) Adhesion assays were performed with HFFF infected with the indicated viruses
Results are means ± SD of triplicate (A–C, G, H, and N), duplicate (D–F), or quadru
(A–M). Two-way ANOVA test. *p < 0.05, **p < 0.01, ***p < 0.001.
Cell Hosassociation between actin in the target cell and the IS in the
effector cell, andUL135 expression results in a reduced capacity
to organize the IS in the effector cell. This HCMV NK evasion
function implies that the actin cytoskeleton in target cells plays
a key role in IS formation and proposes another mechanism by
which infectious agents can evade immune recognition.
RESULTS
UL135 Inhibits NK Cells
Given that the HCMVUL/b’ region plays a major role in promoting
resistance toNKcell attack, 19genesencodedwithinUL/b’ region
were inserted into a replication-deficient adenovirus (RAd) vector,
and their expression was validated (Figure S1A available online).
Then, this expression library was systematically screened in
NK-cell-functional assays, and pUL135, gpUL141, and gpUL142
were identified as eliciting significant protection against NK-
cell-mediated cytolysis (Figure S1B). As recognized NK cell
modulatory functions, gpUL141 and gpUL142 served as positive
controls, whereas the protection elicited by pUL135 provided
evidence that this gene had an NK cell modulatory function.
The levels of protection elicited by pUL135 rivalled those
achieved with gpUL141. In a representative chromium release
assay, pUL135 reduced specific lysis by 64% at an E:T ratio of
40:1 with the immortalized NKL cell line (Figure 1A). In cytolysis
assays, pUL135 also elicited protection against a heterogeneous
primary NK cell population, irrespective of whether assays were
performed in an allogeneic (Figure 1B) or an autologous setting
(Figure 1C). In the autologous assay, pUL135 elicited 49.5%
inhibition of NK-cell-mediated cytolysis at an E:T ratio of 100:1.
Moreover, using a CD107-mobilization assay, protection was
elicited against IFN-a-activated NK cells from 13 different
donors. In allogeneic assays, NK cell degranulation of ten bulk
cultures was significantly inhibited by pUL135 expression with
a mean difference of 36.8% inhibition (Figure 1D). Efficient
pUL135-mediated inhibition was also observed in autologous
NK degranulation assays with peripheral blood mononuclear
cell (PBMC) bulk cultures from three other donors with an
average inhibition of 42.2% (Figure 1E). A panel of 57 NK cell
clones from two donors were expanded following single-cell
sorting (Table 1). In autologous assays, 25 of 57 clones were
either unable to kill target cells or not substantially affected byFN-g Production and Adhesion as Well as T Cell Degranulation and
AR (A), IFN-a-activated T-cell-depleted PBMC against HFFF-hCAR (B), or
C). NK cell degranulation assays were performed with IFN-a-activated PBMC
HFFF-hCAR.
or empty control vector (RAd-Ctrl) and NK cells.
-5 pulsed with antigenic peptide. T cells incubated with PMA-iono or without
p65 (J) T cell lines against autologous SF infected with RAd-Ctrl or RAd-UL135
nst allogeneic HFFF-hCAR (K) or autologous SF infected for 48 hr with HCMV
RAd-UL135, RAd-UL141, and RAd-Ctrl (L).
t autologous SF either mock infected or infected with Merlin or MerlinDUL135.
and NK cells. Results from three experiments were normalized and combined.
plicate (I–M) samples and are representative of three independent experiments
t & Microbe 16, 201–214, August 13, 2014 ª2014 The Authors 203
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were all inhibited by pUL135. Although 33% of clones were
inhibited by gpUL141, 12.3% were still activated. In contrast,
pUL135 was exclusively associated with an inhibitory response
in this series of experiments. In addition to direct killing of target
cells by cell-mediated cytotoxicity, inflammatory cytokines
released by NK cells play a crucial role in suppressing virus
replication; IFN-g expression was suppressed when NK cells
were cocultured with targets expressing either pUL135 or
gpUL141 in comparison to vector control (Figure 1F). NK activa-
tion requires the establishment of cell:cell contact culminating in
formation of an IS, and UL135 reduced the efficiency of NK cells
adhesion to fibroblast targets (Figure 1G).
When expressed in isolation, pUL135 inhibited the NKL cell
line, primary NK cell cultures from >13 different donors, and
the majority of NK cell clones tested. Protection was observed
in both an allogeneic and autologous setting. Moreover, pUL135
suppressed NK-cell-mediated cytolysis, degranulation, IFN-g
expression, and adhesion to target cells.
UL135 Inhibits CD8+ T Cells
Next, we expanded the breadth of the study by investigating
whether pUL135 impacted T cell recognition. A HLA-A*0201-
restricted T cell clone specific for a human papillomavirus 16
E6 epitope was coincubated with MRC-5 fibroblasts (HLA-
A*0201) loaded with specific antigenic peptide (Figure 1H). The
proportion of CD107a+ T cells increased with the amount of
specific peptide loaded on target cells, and pUL135-specific
inhibition occurred in the presence of 0.1mg/ml peptide. To
further characterize this effect, IFN-g production was measured
from two HCMV-specific HLA-A*0201-restricted T cell lines
generated from a donor with tetramer detectable responses
against dominant IE1 and pp65 epitopes. At assay, the T cell
lines contained >70% tetramer-positive cells. When incubated
with autologous fibroblasts coated with specific peptide, there
was a strong pUL135-specific inhibition of IFN-g production
(Figures 1I and 1J). Therefore, pUL135 efficiently suppressed
both NK cell and T cell functions.
UL135 Functions during Productive HCMV Infection
An important test for any HCMV immune evasion gene is
whether it functions in the context of virus infection. The
HCMV strain AD169 lacks the UL/b’ sequence, and therefore
UL135, UL141, and UL142, and provides substantially less pro-
tection against NK cells than strain Merlin. Deletion of either
UL135 or UL141 from strain Merlin resulted in an increase in
NK cell degranulation, whereas deletion of both genes had
an additive effect. Comparable results were obtained when
primary NK cells from volunteer donors were tested against
allogeneic (Figure 1K) or autologous cells (Figure 1L). The ability
of pUL135 to protect against T cell degranulation was also
tested in the context of HCMV infection (Figure 1M). A particu-
larly active pp65-specific T cell line recognized autologous
HCMV-infected cells despite viral-mediated downregulation of
MHC-I, and deletion of UL135 from the HCMV genome resulted
in an increase in T cell degranulation. Merlin reduced the ability
of infected cells to form conjugates with NK cells, and this
ability was inhibited when UL135 was deleted from the genome
(Figure 1N). Whether expressed in isolation or during produc-204 Cell Host & Microbe 16, 201–214, August 13, 2014 ª2014 The Ative HCMV infection, pUL135 promoted evasion of both NK
and T cells.
UL135 Expression
UL135 exhibits a high degree of sequence conservation in char-
acterized HCMV strains and clinical isolates. An ortholog is pre-
sent in chimpanzee cytomegalovirus (CMV) but not CMV species
of the lower primates (Umashankar et al., 2011). pUL135 is
exceptionally proline-rich (60 of 308 amino acids [aa]), contrib-
uting to predictions that it contains 22 potential SH3 binding sites
and is 80% ‘‘structurally disordered.’’ pUL135 was expressed at
slightly higher levels from RAd-UL135 in comparison to HCMV
(Figure S2A) and was synthesized as two species with molecular
masses of 38kDa and 40kDa in comparison to a predicted size
of 33 kDa. During productive HCMV infection, pUL135 was
expressed during early phase (24 hr), but, unusually for an
HCMV gene, levels declined through the late phase (Figure 2A).
pUL135 is membrane associated (Umashankar et al., 2011) and
predicted to contain an N-terminal transmembrane domain and
two N- and 42 O-linked glycosylation sites. However, it was not
sensitive to PNGaseF or O-glycosidase, indicating these glyco-
sylation sites were not used (Figure S2B). In order to optimize
detection in the context of HCMV infection, a sequence
providing a C-terminal V5 tag was inserted into UL135. When
expressed in isolation from RAd-UL135,or in the context of
HCMV infection, pUL135 colocalized with markers of the Golgi
apparatus and at the plasma membrane (Figure 2B). Golgi
localization was more prominent when UL135 was expressed
in isolation, most likely because of the expression of other
HCMV genes and reorganization of the Golgi apparatus, during
infection. A monoclonal antibody raised to pUL135 was able to
detect the protein on cells only once they had been permeabi-
lized (Figure 2C). The data imply that pUL135 is anchored in
the Golgi and plasmamembranes via its N-terminal hydrophobic
domain with themain body of the protein exposed to the cytosol,
which is consistent with previous data (Umashankar et al., 2011).
This topological orientation in the plasma membrane would
make it difficult for pUL135 to act directly as an inhibitory ligand.
UL135 Remodels the Actin Cytoskeleton
Expression of pUL135 in fibroblasts consistently induced dra-
matic changes in cell morphology, and focal adhesions and
cell projections are lost as cells are rounded up (Figures 2D
and S2C). Even in the context of productive infection, pUL135
clearly influenced the HCMV-induced cytopathic effect. In
contrast to parental virus, cells infected with MerlinDUL135
were clearly ‘‘flatter’’ and more spread out, which is indicative
of enhanced adherence (Figures 2E and S2D). The actin cyto-
skeleton was stained with phalloidin; pUL135 expression re-
sulted in elimination of F-actin stress fibers from the cell center,
whereas the cortical actin matrix underlying the plasma mem-
brane appeared reinforced and colocalized with pUL135 (Fig-
ures 3A and S3A). During productive HCMV infection, F-actin
was lost from the center of infected cells, and UL135 colocalized
with cortical actin. However, in the absence of pUL135, a
substantial proportion of F-actin remained in the center of
infected cells (Figures 3B and S3B). In contrast, microtubules
and intermediate filaments were not overtly displaced by
pUL135 (Figures S3C–S3F).uthors
Figure 2. Expression of UL135
(A) HFFF-hCAR were infected with RAd-UL135 or an empty control vector
(RAd-Ctrl) for 48 hr, and HFFF were mock infected (M) or infected with HCMV
strain Merlin or MerlinDUL135 for the indicated times. Proteins were separated
by SDS-PAGE, and western blot was performed for UL135 (V5 antibody) or
actin.
(B) HFFF-hCAR were infected with RAd-UL135 or RAd-Ctrl for 48 hr, and
samples were stained for UL135 (V5 antibody) and giantin (golgi marker). HFFF
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Cell HosAn Intact Actin Cytoskeleton Is Required for NK Cell
Recognition
pUL135 remodeled the actin cytoskeleton and inhibited both
NK and T cell activation. NK and T cell modulatory functions
generally act by either promoting cell-surface expression of
an inhibitory ligand or suppressing an activating ligand; how-
ever, pUL135 did not alter the expression of any candidate
ligands or adhesion molecules (Table S1). Therefore, we inves-
tigated whether pUL135’s capacity to remodel the cytoskel-
eton was involved in immune evasion. The inhibitor of actin
polymerization latrunculin A (LatA) reproducibly suppressed
NK cell activation against control cells in a concentration-
dependent manner, ultimately reaching levels comparable to
those achieved with pUL135 (Figure 3C). Comparable results
were obtained following HCMV infection in the presence or
absence of pUL135 (Figure 3D). Remarkably, in the presence
of pUL135, LatA did not suppress NK cell activation. The fact
that the effects of LatA and pUL135 were not additive sug-
gested that they exerted their effect via the same mechanism.
In support of this hypothesis, F-actin in cells expressing
pUL135 (Rad-UL135/Merlin) was unaffected by LatA treatment.
In contrast, cells lacking pUL135 (RAd-Ctrl/MerlinDUL135/
Mock) displayed progressive loss of central actin as LatA
concentrations increased until, at high concentrations, they
resembled pUL135-expressing cells; i.e., a rounded cell devoid
of central actin fibers (Figures 3E, S3G, and S3H).
Similar results were obtained with the actin-stabilizing drug
jasplakinolide. Treatment of fibroblasts with jasplakinolide led
to loss of stress fibers and the formation of an F-actin aggresome
(Figure S3I), which correlated with a reduction in NK degranula-
tion (Figure S3J). Treatment of cells expressing pUL135 with
moderate concentrations of jasplakinolide had little effect on
pUL135-mediated actin remodeling or NK degranulation. At
high concentrations, there was complete loss of stress fibers in
both control and pUL135-expressing cells, and NK degranula-
tion was equivalent in both.
Thus, actin is required for NK recognition of targets, and,
following modification of actin by LatA or jasplakinolide, control
cells inhibit NK degranulation to the same extent as pUL135-
expressing cells.UL135 InteractswithMembers of theWAVE2Regulatory
Complex and Talin
Yeast two-hybrid assays and stable isotope labeling by amino
acids in cell culture (SILAC) immunoprecipitation experi-
ments were undertaken in order to identify pUL135-inter-
acting partners. In the yeast two-hybrid screen, ABI1 and
ABI2 were both identified in multiple clones. This finding was
consolidated and expanded when SILAC immunoprecipita-
tion experiments performed on pUL135-expressing fibroblastswere infected with the indicated strains of HCMV for 48 hr and stained for
UL135 (V5 antibody) or IE1/IE2 (MerlinDUL135) and giantin.
(C) HFFF were infected with the indicated strains of HCMV and stained for
either surface or intracellular UL135 expression 48 hr later.
(D and E) Brightfield images of HFFF-hCAR infected with RAd-UL135 or
RAd-Ctrl (D) and HFFF (E) mock infected or infected with HCMV strain Merlin
or MerlinDUL135 for 48 hr.
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Figure 3. UL135 Modifies Actin Structure
(A–D) HFFF-hCAR were infected with RAd-UL135
or RAd-Ctrl (A and C), or HFFF were infected with
HCMV strain Merlin or MerlinDUL135 or mock
infected (B and D). Samples were stained 48 hr
postinfection for UL135 (V5 antibody) and actin
(phalloidin; A and B). Following infection, samples
were incubated with the indicated doses of LatA
(LatA; C and D).NK cell degranulation assays were
performed 48 hr postinfection with IFN-a-activated
PBMC. Results are mean ± SD and are represen-
tative of three independent experiments. Two-way
ANOVA test with post tests were performed be-
tween RAd-Ctrl and RAd-UL135 (C) or Merlin
and MerlinDUL135 (D). *p < 0.05, **p < 0.01, ***p <
0.001.
(E) Samples treated as in (C and D) were stained
for actin (phalloidin).
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Significantly ABI1, ABI2, NAP1, CYFIP1, and WAVE2 itself
are all components of the WAVE2 regulatory complex (WRC),
which regulates the actin nucleator Arp2/3 (Takenawa and
Suetsugu, 2007). The interaction with WAVE2, ABI1, ABI2,
NAP1, CYFIP1, and talin-1 were validated in conventional
immunoprecipitation experiments when pUL135 was ex-
pressed in both isolation and the context of HCMV infection
(Figure 4A).206 Cell Host & Microbe 16, 201–214, August 13, 2014 ª2014 The AuthorsABI1 (Figures 4B and 4C), ABI2 (Figures
S4A and S4B), and WAVE2 (Figures 4D
and 4E) all exhibited a diffuse cellular dis-
tribution that excluded the nucleus as well
as a marked association with membrane
protrusions, consistent with their role in
actin remodelling. Whether pUL135 was
expressed in isolation or during produc-
tive HCMV infection, all three cellular
proteins trafficked with pUL135 to the
Golgi apparatus (Figures S4C–S4F) and
colocalized evenly around the plasma
membrane. ABI1 and ABI2 were more
readily imaged in cells expressing pUL135,
even though their absolute abundance
remained constant as assessed by west-
ern blot and flow cytometry (Figures 4F
and 4G; data not shown). pUL135 also
efficiently colocalized with ABI1 and ABI2
when expressed with a C-terminal GFP
tag (Figures S4G and S4H). pUL135 inter-
acted and localized with ABI1, ABI2,
and WAVE2 at the Golgi apparatus and
plasma membrane without changing their
overall abundance.
Talin-1 binds actin and participates in
focal adhesions but is not a member of
the WRC. pUL135 expression alone was
sufficient to recruit talin-1 to the Golgi
apparatus and cell membrane, but, rather
than stimulating cell adhesion, focaladhesions were disrupted (Figure 4H). pUL135 is not needed
for HCMV to disrupt focal adhesions (Stanton et al., 2007) yet
was required for talin-1 to be redistributed to the cell periphery
during HCMV infection (Figure 4I).
UL135 Inhibits Cytoskeletal Remodelling
pUL135 consistently induced cell rounding, loss of contact
adhesions, and disassembly of stress fibers. RNA interference
was used to investigate the roles played by the various
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both ABI1 and ABI2 (ABI1/ABI2) was associated with a very
slight reduction in F-actin levels in control cells, consistent with
a requirement for ABI1/ABI2 in the WRC (Figures 5A andS5B).
In contrast, pUL135 expression induced a very dramatic loss
of F-actin. Moreover, following ABI1/ABI2 knockdown, pUL135
lost the capacity to depolymerize F-actin fibers throughout the
center of the cell. This implies that, rather than directly inhibiting
ABI1/ABI2, pUL135 is commandeering the WRC to actively pro-
mote F-actin depolymerization. To determine whether the entire
WRC was involved in pUL135-mediated actin remodelling, the
WRC member CYFIP1 was targeted with small interfering RNA
(siRNA). Although knockdown had no obvious effect on actin,
CYFIP1 was required for pUL135-mediated depolymerization
of actin (Figures 5B and S5C). Therefore, ABI1/ABI2 was not
the only WRC component necessary for pUL135-mediated actin
remodelling.
Talin binds the cytosolic domain of integrins at focal adhe-
sions, at which point it provides a bridge between the actin cyto-
skeleton and the extracellular matrix (Kim et al., 2011), playing a
key role in activating integrin function in inside-out signaling.
pUL135 inhibited cell spreading on fibronectin; this phenotype
was also inhibited by knockdown of ABI1/ABI2 but not talin-1
and talin-2 (Figures 5C and 5D). In order to investigate the inter-
action between pUL135 and theWRC, pUL135 was immunopre-
cipitated from cells in which ABI1/ABI2 had been knocked down
(Figures 5E and S5D). Knockdown of any member of the WRC
can lead to loss of other members of the complex, yet the inter-
action of pUL135 with talin was clearly unaffected, which is
consistent with pUL135 binding talin independently of its inter-
action with the WRC.
A series of in-frame deletions were generated through
UL135, and the resulting gene products tested for their
capacity to bind ABI1/ABI2 and talin (Figure S5E). The center
of pUL135 (aa 169–206) was required for the interaction with
theWRC, but not talin. TheC terminus (aa 275–308) was required
for the interaction with talin (Figures 5F and S5F). In agreement
with siRNA studies, the interaction between pUL135 and the
WRC was responsible for the loss of central F-actin fibers (Fig-
ures 5G and S5G). The D169–206 mutant failed to redistribute
ABI1/ABI2, which instead concentrated in membrane protru-
sions around the periphery of the cell (Figure 5H, arrowed). Like-
wise, deletion of the talin-binding domain (aa 275–308) resulted
in talin no longer colocalizing with pUL135 but instead con-
centrating in punctate structures around the cell periphery
(Figure 5I, arrowed). Deletion of either the ABI1/ABI2 or talin
interaction domains partially restored the capacity of cells to
spread on a fibronectin matrix, and deletion of both domains
eliminated the phenotype completely (Figure 5J). Thus, pUL135
affected cell adhesion by two mechanisms: (1) through the
interaction with ABI1/ABI2, pUL135 actively disassembled
the actin framework that the extracellular matrix is attached to
and, (2) interacting directly with talin, pUL135 disrupted focal
adhesions and suppressed integrin function. Targeting ABI1/
ABI2 by either siRNA or mutation released the WRC and
restored cell spreading. Deleting the talin-interacting domain
also restored cell spreading, but talin knockdown in pUL135-
expressing cells did not, implying that pUL135 directly sup-
pressed talin function.Cell HosThe Interaction of UL135 with ABI1/ABI2 Is Required
for Inhibition of NK Cells
The functional significance of the interaction of pUL135 with
ABI1/ABI2 and talin in eliciting protection against NK cells was
investigated with siRNA. The interaction with ABI1/ABI2, rather
than talin, was critical for NK cell evasion whether assessed by
CD107a mobilization (Figures 6A and 6B) or cytolysis assays
(Figures 6C and 6D). This correlation was supported in experi-
ments utilizing the characterized pUL135 deletion mutants.
Only versions of pUL135 that bound ABI1/ABI2 elicited protec-
tion against NK cells (Figure 6E). Indeed, pUL135 functioned
even more effectively as an NK evasion function when the
talin-interacting domain was deleted. pUL135’s direct interac-
tion with ABI1/ABI2 was not sufficient, a second WRC member
(CYFIP1) was also required for pUL135 in order to induce
protection against NK cell attack (Figure 6F). The recruitment
of the entire WRC is thus implicated in pUL135 function. In the
absence of pUL135, neither the ablation of ABI1/ABI2 nor
CYFIP1 had an impact on NK cell recognition, indicating that
pUL135 used ABI1/ABI2 to recruit the WRC and then subverted
its activity to suppress NK cells.
Additional evidence for this hypothesis was provided in exper-
iments in which ABI1/ABI2 was overexpressed. Overexpression
of ABI1/ABI2 in the presence of pUL135 resulted in increased
recruitment of ABI by UL135, yet it decreased the recruitment
of WAVE2 (Figure S6A). This was interpreted as being due to
an excess of monomeric ABI1/ABI2, which saturated pUL135
and prevented the recruitment of ABI1/ABI2 found in the WRC.
This correlated with reduced modification of actin by pUL135
(Figures S6B and S6C) and a reduced ability for pUL135 to inhibit
NK degranulation (Figure 6G). Overexpression of ABI1/ABI2 in
the absence of pUL135 did not affect NK degranulation.
UL135 Inhibits the Formation of an Immune Synapse
pUL135-mediated protection against immune effector cells de-
pended on its interaction with ABI1/ABI2 and capacity to disrupt
and/or remodel the actin cytoskeleton. Furthermore, a specific
inhibitor of actin polymerization recapitulated this effect. More-
over, NK cells were less able to adhere to cells expressing
pUL135. To progress our understanding of pUL135 function,
the IS was imaged directly during NK cell recognition. Following
coculture of fibroblasts with NK cells, bona fide ISs were readily
detected at sites of cell:cell contacts, as demonstrated by a ring
of polymerized actin indicative of NK cell activation and synapse
formation (Figure 6H, RAd-Ctrl). When pUL135 was expressed in
target cells, ISs were less common, their morphology was less
defined, and actin polymerization at the IS was much reduced
(Figures 6H and 6I). Phalloidin selectively labeled long F-actin
filaments within the target cell. Interestingly, these frequently
delineated the inner or outer limits of actin polymerization within
the actin ring formed by the activated NK cell (Figure 6J). To
unambiguously differentiate the actin in the target cell from
that in the NK cell, fibroblasts were engineered to express a
Citrine-labeled live-cell actin marker lifeact, whereas NKL cells
expressed mCherry-tagged lifeact. Fluorescent labeling clearly
differentiated between the ‘‘red’’ actin ring associated with the
IS in the NK cell and the underlying ‘‘green’’ actin fibers within
the target cell (Figures 6K–6M). Like phalloidin staining, synap-
ses were much less common when UL135 was expressed int & Microbe 16, 201–214, August 13, 2014 ª2014 The Authors 207
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structure was absent (Figure 6K). Lifeact imaging also revealed
that the actin ring within the NK cell was delineated by, and
commonly aligned with, the actin fibers within the target cell
(Figures 6L and S6D). Moreover, we observed that actin poly-
merization within the actin ring formed by the effector cell was
clearly less dense where it ‘‘intersected’’ with actin fibers in
the target cell (Figure 6M), consistent with the structure of the
cytoskeleton within the target cell influencing synapse formation
in the effector cell. Therefore, we propose that F-actin filaments
within the target cell play an important role in the formation and
structure of the synapse in the NK cell, and pUL135 may inhibit
synaptogenesis by derailing this process.
DISCUSSION
The UL/b’ sequence (UL133–UL150) is an important determi-
nant of HCMV pathogenesis in vivo that harbors a striking con-
centration of genes implicated in controlling host immunity;
these include a potentiator of tumor necrosis factor a (TNF-a)
signaling (UL138) (Le et al., 2011), NK cell evasion functions
UL141 and UL142 (Wilkinson et al., 2008), TNF receptor homo-
log UL144 (Benedict et al., 1999), and IL-8-like virokine UL146
(Penfold et al., 1999). By promoting evasion of both NK and
T cell recognition, pUL135 can be expected to contribute
toward the increased virulence bestowed by HCMVUL/b’. More-
over, being encoded within the latency-associated UL133–
UL138 transcriptional unit, UL135 has the potential to confer
immune protection during virus reactivation in differentiating
myeloid cells. Nevertheless, pUL135 is efficiently expressed dur-
ing productive infection, reaching peak levels at 24 hr postinfec-
tion, and makes a major contribution toward the characteristic
cytopathic effect of clinical HCMV strains.
The profound effect pUL135 exerts on cellular morphology
was mediated by two distinct mechanisms acting independently
through talin and ABI1/ABI2. Integrins are heterodimeric integral
membrane proteins that link the cytoskeleton with extracellular
matrix (Kim et al., 2011). Bidirectional signaling through integrins
plays a crucial role in regulating cell proliferation, survival, tran-
scription, migration, and cytoskeletal organization. The N-termi-
nal FERM domain of talin attaches to the cytoplasmic tail of the
b-integrin subunit, whereas its C-terminal rod domain binds
actin. Talin is not merely a molecular bridge but a key regulator
of inside-out signaling and, hence, integrin activation. pUL135
and talin-1 participated in a stable complex at the plasma
membrane that correlated with disruption of focal adhesins
and suppression of contacts with the extracellular matrix.
Although integrins play a major role in immune recognition by
cytotoxic cells, talin knockdown had no discernible impact on
pUL135’s capacity to suppress NK cell function. Indeed, dele-
tion of the talin binding domain actually increased the ability ofFigure 4. UL135 Interacts with the WAVE2 Complex and Talin
(A) HFFF-hCAR were infected with RAd-UL135 or RAd-Ctrl, and HFFF were in
postinfection, and immunoprecipitation was performed for the V5 tag on UL135. P
indicated proteins.
(B–I) HFFF-hCARwere infected with RAd-UL135 or RAd-Ctrl (B, D, F, and H), and
(C, E, G, and I). Samples were fixed and stained for UL135 (V5 antibody) and ABI1
lysed, and SDS-PAGE was performed 48 hr postinfection (F) or at the indicated
Cell HospUL135 to inhibit NK cells. Beyond immune evasion, HCMV con-
trols the motility and differentiation of infected cells in order to
promote virus dissemination, and infection of endothelial cells
can promote transendothelial migration of infected monocytes
by increasing the permeability of the endothelium (Bentz et al.,
2006). By inhibiting the ability of the cell to interact with the
extracellular matrix, pUL135 has the potential to affect these
processes.
The adaptor proteins ABI1 and ABI2 play a major role in pro-
moting actin polymerization through their interaction with mena
(Tani et al., 2003), the diaphenous-like formins (Ryu et al.,
2009), N-WASP, andWAVE1–WAVE3 (Takenawa and Suetsugu,
2007). We demonstrated that pUL135 bound directly to ABI1/
ABI2 and recruited members of the WRC, including WAVE2,
CYFIP1, and NAP1. The WRC promotes actin polymerization
following recruitment of profilin, actin, and the Arp2/Arp3 com-
plex. However, in recruiting the WRC rather than promoting
actin polymerization, pUL135 induced the selective loss of stress
fibers, whereas cortical actin was preserved. The effect is most
readily observed when pUL135 is expressed in isolation, given
that HCMV encodes additional functions that impact on actin
(Seo et al., 2011) and adhesion junctions (Stanton et al., 2007).
Remodeling of the actin cytoskeleton is not only instrumental
in a range of cellular processes including motility, polarity, sur-
vival, and replication but is also implicated in the entry, assem-
bly, replication, egress, and spread of innumerable viruses and
intracellular bacteria (Taylor et al., 2011). Although pUL135 has
the potential to impact on diverse cellular and viral processes,
the gene is dispensable in vitro. pUL135 is an extremely effective
NK and T cell evasion function, which operates against the back-
ground of a number of other HCMV encoded immune evasins.
Orchestrated reorganization of the actin cytoskeleton is critical
within the cytotoxic cell to promote adherence to the target
cell, polarization of cytolytic granules, organization of the
immunological synapse, and degranulation. The nucleation-pro-
moting factor WASp and the Arp2/Arp3 complex are recruited
to the NK cell synapse (Butler and Cooper, 2009; Mace et al.,
2010; Orange, 2008; Rak et al., 2011), whereas actin polymeriza-
tion induced byWASp andWAVE2 are critical for T cell activation
and IS formation (Billadeau et al., 2007). F-actin accumulation
at the synapse is a prerequisite for cytotoxic synapses and is
required for granule secretion, whereas inhibitory NK synapses
are characterized by a lack of an actin ring assembly (Brown
et al., 2011; Orange, 2008; Rak et al., 2011). However, there is
surprisingly little information regarding the role of actin in target
cells. Our imaging studies imply that F-actin fibers provide
a framework for the IS. This foundation is undermined in
pUL135-expressing cells and correlated with pUL135’s capacity
to modify F-actin through its interaction with the WRC. A role for
the cytoskeleton is indicated both by pUL135’s requirement for
ABI1/ABI2 and CYFIP1, and pUL135’s inability to suppress NKfected with HCMV strain Merlin or MerlinDUL135. Samples were lysed 48 hr
roteins were separated by SDS-PAGE, and western blot was performed for the
HFFF were infected with HCMV strain Merlin or MerlinDUL135 or mock infected
(B and C), WAVE2 (D and E), or talin (H and I) 48 hr postinfection. Samples were
time points (G) followed by western blot for the indicated proteins.
t & Microbe 16, 201–214, August 13, 2014 ª2014 The Authors 209
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knockdown nor overexpression of ABI1/ABI2 or CYFIP1 in target
cells impacted on NK cell activation, indicating that the interac-
tion of pUL135with theWRC involvesmore than simple inhibition
of WRC function.
When expressed in isolation, pUL135-mediated disruption of
F-actin was associated with the elimination of lamellipodia, filo-
podia, and nanotubes; by itself, this could reduce recruitment of
the cytotoxic cell by the target (Davis and Sowinski, 2008).Within
the IS, the highly structured supramolecular activation cluster
spatially aligns receptors and adhesionmolecules on the effector
cell with their ligands on the target cell. The actin cytoskeleton
underlies and links to these structures in the target cell, and
disruption of actin in the target has been shown to impair ligand
binding to receptors on the NK cell (Gross et al., 2010). Forma-
tion of the IS was clearly impeded by pUL135, and, when found,
they were misformed and failed to induce the prominent actin
ring structure characteristic of an activating synapse. By imaging
the actin organization at the IS in both the NK and target
cell, it was clear that the actin organization within the target
cell can influence synapse formation by the NK cell by both
delineating the overall extent of the IS and influencing local levels
of actin polymerization on a subsynaptic scale. The important
role played by target cell F-actin in immune cell recognition
is manifest by the remarkable efficiency with which pUL135
suppressed NK and T cell recognition. By preventing the
establishment of a cytotoxic synapse, the viral evasion function
suppressed a wide range of effector cell types and functions.
This mechanism may not be unique to HCMV, given that a
wide range of viruses are known to perturb the actin cytoskel-
eton (Taylor et al., 2011).
EXPERIMENTAL PROCEDURES
Healthy adult volunteers provided blood and dermal fibroblasts following
written informed consent. All procedures were approved by the Cardiff
University School of Medicine Ethics Committee.
Cells and Viruses
Telomerase-immortalized primary SFs, HFFF, HFFF-hCAR, MRC-5, and
293-TREx cells were grown in Dulbecco’s modified Eagle’s medium (DMEM;Figure 5. UL135 Interacts Independently with the WRC and Talin and I
(A–E) HFFF-hCAR were transfected with control siRNA (siRNA-Ctrl), siRNA again
TLN1/2), or siRNA against CYFIP1. They were infected with RAd-UL135 or RAd-
(A and B) Cells were fixed and stained for actin (phalloidin).
(C and D) Cells were allowed to adhere to fibronectin-coated dishes for 30 min
counted by microscopy. Four separate fields were counted; results are mean ± SD
***p < 0.001.
(E) Cells were lysed, and UL135 was immunoprecipitated with its V5 tag. Immun
performed for the indicated proteins.
(F–J) HFFF-hCAR were infected with the indicated adenovirus vectors, and assa
(F) UL135 was immunoprecipitated with the V5 tag. Immunoprecipitated prote
indicated proteins.
(G) Cells were fixed and stained for actin (phalloidin).
(H) Cells were fixed and stained for UL135 (V5 antibody) and ABI1. Accumulation
(I) Cells were stained for UL135 (V5 antibody) and talin. Accumulation of talin at
(J) Cells were allowed to adhere to fibronectin-coated dishes for 30 min and then
microscopy. Four separate fields were counted; results are mean ± SD and are r
0.001.
Cell Hos10% fetal calf serum [FCS]), and primary NK cells were cultured as described
previously (Morris et al., 2005; Prod’homme et al., 2007). HCMV IE1- and
pp65-specific T cell lines were expanded by coculture with irradiated pep-
tide-coated autologous fibroblasts in RPMI medium (10% FCS, 2% human
AB serum, and 10 IU/ml IL-2). The HPV16 E6 T cell clone 7E7 has been
described previously (Evans et al., 2001). F-actin binding lifeact peptide (Riedl
et al., 2008) tagged with mCherry or mCitrine was expressed from retrovirus
vectors. HCMV was derived from bacterial-artificial-chromosome-cloned
strain Merlin (RL13 and UL128) genome (Stanton et al., 2010). Merlin-
DUL135 was constructed via recombineering in order to delete the first
687 bp of UL135. All virus stocks were sequenced (MiSeq) following recon-
stitution. Recombinant adenoviruses were generated with the AdZ system
(Stanton et al., 2008).
Immunohistochemistry
Immunofluorescence and western transfers were performed as described
previously (Stanton et al., 2010). For HCMV-infected cells, coverslips were
precoated with 10 mg/ml fibronectin in order to provide greater adhesion.
There was no difference in the ability of Merlin or Merlin-DUL135 to bind to
fibronectin (data not shown). Coverslips were blocked with human serum prior
to applying primary antibody. For detection of immune synapses, NKL cells
were added 15 min before fixation followed by staining with Phalloidin Atto-
647N. Images were analyzed with ImageJ (National Institutes of Health).
Immunoprecipitation and Yeast Two-Hybrid
Cells were lysed with IP Lysis Buffer (Pierce Biotechnology) containing 2 mM
Na3VO4, 2 mM NaF, and protease inhibitors (Sigma-Aldrich) for 30 min and
centrifuged at 12,000 3 g for 30 min, and then 25 ml anti-V5 agarose (Abcam)
was added. Samples were rotated for 3 hr and washed three times, and then
proteins were eluted in NuPAGE SDS sample buffer. Samples were subjected
to SDS-PAGE followed by either western transfer or SILAC mass spectros-
copy as previously described (Weekes et al., 2012). Yeast two-hybrid
screening was performed as described previously (Striebinger et al., 2013).
siRNA
Cells were transfected with Lipofectamine RNAiMAX (Invitrogen) according
to manufacturers’ instructions. Cells were infected with RAd or HCMV 24 hr
posttransfection and then assayed 48 hr postinfection.
Adhesion and Spreading Assays
Target and NK cells were incubated for 15 min at 37C in 1 mg/ml CFDA-SE.
Cell Tracer or 0.25 mg/ml DDAO-SE (Invitrogen) were used, respectively. Cells
were washed and incubated at 37C for 30 min. Equal quantities of NK and
target cells were mixed and incubated at 37C for 10 min. Cells were fixed in
4% paraformaldehyde before fluorescence-activated cell sorting acquisition.
Spreading assays were performed as described previously (Humphries, 2009).nhibits Cytoskeletal Remodelling
st ABI1 and ABI2 (siRNA-ABI1/ABI2), siRNA against talin-1 and talin-2 (siRNA-
Ctrl 24 hr later. Assays were performed 48 hr postinfection.
and then fixed, and the number of cells exhibiting a spread morphology was
and representative of three independent experiments. Two-way ANOVA test.
oprecipitated proteins were separated by SDS-PAGE, and western blot was
ys were performed at 48 hr postinfection.
ins were separated by SDS-PAGE, and western blot was performed for the
of ABI1 at sites of actin protrusions are indicated with arrows.
sites resembling focal adhesions are indicated with arrows.
fixed, and the number of cells exhibiting a spread morphology was counted by
epresentative of three independent experiments. One-way ANOVA test. ***p <
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Figure 6. Interactions with ABI1/ABI2 Are Required for UL135 to Protect Against NK Cells
(A and B) HFFF-hCAR were transfected with control siRNA (siRNA-Ctrl), siRNA against ABI1 and ABI2 (siRNA-ABI1/ABI2), or siRNA against talin-1 and talin-2
(siRNA-TLN1/2). They were infected 24 hr later with RAd-UL135 or RAd-Ctrl. NK degranulation assays were performed 48 hr postinfection with IFN-a-activated
PBMC.
(legend continued on next page)
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NK cytotoxicity was measured with Cr51 release (Aicheler and Stanton, 2013).
Degranulation assays were performed as described previously (Prod’homme
et al., 2007). For 7E7 T cell stimulation, HLA-A*0201 MRC-5 targets were incu-
bated for 1 hr at 37Cwith HPV16 E629–38 peptide (TIHDIILECV). For T cell lines
generated from donor D7, autologous fibroblasts were coated with IE1
(VLEETSVML), pp65 (NLVPMVATV), or irrelevant peptide at 100 mg/ml. For
IFN-g assays, cells were stained with combinations of anti-CD3-PerCP, anti-
CD8-APC, or anti-CD56-APC before fixation, permeabilization, and intracel-
lular cytokine staining with anti-IFN-g-FITC or anti-IFN-g-PE (BD Biosciences).
For assays in the presence of LatA and jasplakinolide, cells were maintained
in the drug until the CD107a assay. Cells were washed, PBMC was added,
and the assay performed. Limited recovery of actin polymerization occurred
during the CD107a assay following LatA treatment (Figures S7A and S7B),
and none occurred following jasplakinolide treatment (Figure S7C).
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